[
  {
    "case_id": "case_001",
    "drugs": [
      "warfarin",
      "aspirin",
      "metoprolol"
    ],
    "kg_risk_level": "HIGH",
    "kg_risk_score": 0.6337667709872787,
    "kg_interactions": [
      {
        "drug1": "warfarin",
        "drug2": "acetylsalicylic acid",
        "drug1_id": "DB00682",
        "drug2_id": "DB00945",
        "severity": "Major interaction",
        "severity_score": 7.0,
        "description": "Acetylsalicylic acid may increase the anticoagulant activities of Warfarin."
      },
      {
        "drug1": "warfarin",
        "drug2": "metoprolol",
        "drug1_id": "DB00682",
        "drug2_id": "DB00264",
        "severity": "Major interaction",
        "severity_score": 7.0,
        "description": "Metoprolol may decrease the excretion rate of Warfarin which could result in a higher serum level."
      },
      {
        "drug1": "acetylsalicylic acid",
        "drug2": "metoprolol",
        "drug1_id": "DB00945",
        "drug2_id": "DB00264",
        "severity": "Major interaction",
        "severity_score": 7.0,
        "description": "Acetylsalicylic acid may decrease the antihypertensive activities of Metoprolol."
      }
    ],
    "template_explanation": "\ud83d\udfe0 HIGH RISK IDENTIFIED (Score: 0.63)\n\nThis medication combination has SIGNIFICANT interaction risks:\n\u2022 Major drug interactions detected that require attention\n\u2022 Monitoring and possible medication adjustments recommended\n\nKey interactions:\n- warfarin + acetylsalicylic acid: Major interaction\n  Description: Acetylsalicylic acid may increase the anticoagulant activities of Warfarin....\n- warfarin + metoprolol: Major interaction\n  Description: Metoprolol may decrease the excretion rate of Warfarin which could result in a higher serum level....\n- acetylsalicylic acid + metoprolol: Major interaction\n  Description: Acetylsalicylic acid may decrease the antihypertensive activities of Metoprolol....\n\nRECOMMENDATION: Schedule appointment with healthcare provider to review medications.",
    "llm_explanation": "[LLM not available]"
  },
  {
    "case_id": "case_002",
    "drugs": [
      "warfarin",
      "ibuprofen",
      "lisinopril"
    ],
    "kg_risk_level": "HIGH",
    "kg_risk_score": 0.7216621750847606,
    "kg_interactions": [
      {
        "drug1": "warfarin",
        "drug2": "ibuprofen",
        "drug1_id": "DB00682",
        "drug2_id": "DB01050",
        "severity": "Contraindicated interaction",
        "severity_score": 10.0,
        "description": "Ibuprofen may decrease the excretion rate of Warfarin which could result in a higher serum level."
      },
      {
        "drug1": "ibuprofen",
        "drug2": "lisinopril",
        "drug1_id": "DB01050",
        "drug2_id": "DB00722",
        "severity": "Contraindicated interaction",
        "severity_score": 10.0,
        "description": "The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Ibuprofen is combined with Lisinopril."
      },
      {
        "drug1": "warfarin",
        "drug2": "lisinopril",
        "drug1_id": "DB00682",
        "drug2_id": "DB00722",
        "severity": "Major interaction",
        "severity_score": 7.0,
        "description": "Lisinopril may decrease the excretion rate of Warfarin which could result in a higher serum level."
      }
    ],
    "template_explanation": "\ud83d\udfe0 HIGH RISK IDENTIFIED (Score: 0.72)\n\nThis medication combination has SIGNIFICANT interaction risks:\n\u2022 Major drug interactions detected that require attention\n\u2022 Monitoring and possible medication adjustments recommended\n\nKey interactions:\n- warfarin + ibuprofen: Contraindicated interaction\n  Description: Ibuprofen may decrease the excretion rate of Warfarin which could result in a higher serum level....\n- ibuprofen + lisinopril: Contraindicated interaction\n  Description: The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Ibuprofen is combined with Lisinopril....\n- warfarin + lisinopril: Major interaction\n  Description: Lisinopril may decrease the excretion rate of Warfarin which could result in a higher serum level....\n\nRECOMMENDATION: Schedule appointment with healthcare provider to review medications.",
    "llm_explanation": "[LLM not available]"
  },
  {
    "case_id": "case_003",
    "drugs": [
      "clopidogrel",
      "omeprazole",
      "aspirin"
    ],
    "kg_risk_level": "MODERATE",
    "kg_risk_score": 0.5492889536063057,
    "kg_interactions": [
      {
        "drug1": "clopidogrel",
        "drug2": "omeprazole",
        "drug1_id": "DB00758",
        "drug2_id": "DB00338",
        "severity": "Contraindicated interaction",
        "severity_score": 10.0,
        "description": "The serum concentration of the active metabolites of Clopidogrel can be reduced when Clopidogrel is used in combination with Omeprazole resulting in a loss in efficacy."
      }
    ],
    "template_explanation": "\ud83d\udfe1 MODERATE RISK (Score: 0.55)\n\nThis medication combination has some interaction concerns:\n\u2022 Interactions detected but generally manageable\n\u2022 Monitoring recommended\n\nKey points:\n- clopidogrel + omeprazole: Contraindicated interaction\n  Description: The serum concentration of the active metabolites of Clopidogrel can be reduced when Clopidogrel is used in combination with Omeprazole resulting in a...\n\nRECOMMENDATION: Discuss at next regular appointment with your provider.",
    "llm_explanation": "[LLM not available]"
  },
  {
    "case_id": "case_004",
    "drugs": [
      "methotrexate",
      "ibuprofen",
      "prednisone"
    ],
    "kg_risk_level": "HIGH",
    "kg_risk_score": 0.6531568576313426,
    "kg_interactions": [
      {
        "drug1": "ibuprofen",
        "drug2": "prednisone",
        "drug1_id": "DB01050",
        "drug2_id": "DB00635",
        "severity": "Contraindicated interaction",
        "severity_score": 10.0,
        "description": "The risk or severity of gastrointestinal irritation can be increased when Prednisone is combined with Ibuprofen."
      },
      {
        "drug1": "methotrexate",
        "drug2": "ibuprofen",
        "drug1_id": "DB00563",
        "drug2_id": "DB01050",
        "severity": "Major interaction",
        "severity_score": 7.0,
        "description": "The serum concentration of Methotrexate can be increased when it is combined with Ibuprofen."
      }
    ],
    "template_explanation": "\ud83d\udfe0 HIGH RISK IDENTIFIED (Score: 0.65)\n\nThis medication combination has SIGNIFICANT interaction risks:\n\u2022 Major drug interactions detected that require attention\n\u2022 Monitoring and possible medication adjustments recommended\n\nKey interactions:\n- ibuprofen + prednisone: Contraindicated interaction\n  Description: The risk or severity of gastrointestinal irritation can be increased when Prednisone is combined with Ibuprofen....\n- methotrexate + ibuprofen: Major interaction\n  Description: The serum concentration of Methotrexate can be increased when it is combined with Ibuprofen....\n\nRECOMMENDATION: Schedule appointment with healthcare provider to review medications.",
    "llm_explanation": "[LLM not available]"
  },
  {
    "case_id": "case_005",
    "drugs": [
      "lithium",
      "ibuprofen",
      "hydrochlorothiazide"
    ],
    "kg_risk_level": "HIGH",
    "kg_risk_score": 0.6685844272508622,
    "kg_interactions": [
      {
        "drug1": "lithium cation",
        "drug2": "ibuprofen",
        "drug1_id": "DB01356",
        "drug2_id": "DB01050",
        "severity": "Contraindicated interaction",
        "severity_score": 10.0,
        "description": "Ibuprofen may decrease the excretion rate of Lithium cation which could result in a higher serum level."
      },
      {
        "drug1": "lithium cation",
        "drug2": "hydrochlorothiazide",
        "drug1_id": "DB01356",
        "drug2_id": "DB00999",
        "severity": "Major interaction",
        "severity_score": 7.0,
        "description": "Hydrochlorothiazide may decrease the excretion rate of Lithium cation which could result in a higher serum level."
      },
      {
        "drug1": "ibuprofen",
        "drug2": "hydrochlorothiazide",
        "drug1_id": "DB01050",
        "drug2_id": "DB00999",
        "severity": "Major interaction",
        "severity_score": 7.0,
        "description": "The excretion of Hydrochlorothiazide can be decreased when combined with Ibuprofen."
      }
    ],
    "template_explanation": "\ud83d\udfe0 HIGH RISK IDENTIFIED (Score: 0.67)\n\nThis medication combination has SIGNIFICANT interaction risks:\n\u2022 Major drug interactions detected that require attention\n\u2022 Monitoring and possible medication adjustments recommended\n\nKey interactions:\n- lithium cation + ibuprofen: Contraindicated interaction\n  Description: Ibuprofen may decrease the excretion rate of Lithium cation which could result in a higher serum level....\n- lithium cation + hydrochlorothiazide: Major interaction\n  Description: Hydrochlorothiazide may decrease the excretion rate of Lithium cation which could result in a higher serum level....\n- ibuprofen + hydrochlorothiazide: Major interaction\n  Description: The excretion of Hydrochlorothiazide can be decreased when combined with Ibuprofen....\n\nRECOMMENDATION: Schedule appointment with healthcare provider to review medications.",
    "llm_explanation": "[LLM not available]"
  },
  {
    "case_id": "case_006",
    "drugs": [
      "digoxin",
      "amiodarone",
      "furosemide"
    ],
    "kg_risk_level": "HIGH",
    "kg_risk_score": 0.7717969225419457,
    "kg_interactions": [
      {
        "drug1": "digoxin",
        "drug2": "furosemide",
        "drug1_id": "DB00390",
        "drug2_id": "DB00695",
        "severity": "Contraindicated interaction",
        "severity_score": 10.0,
        "description": "The risk or severity of adverse effects can be increased when Furosemide is combined with Digoxin."
      },
      {
        "drug1": "amiodarone",
        "drug2": "furosemide",
        "drug1_id": "DB01118",
        "drug2_id": "DB00695",
        "severity": "Contraindicated interaction",
        "severity_score": 10.0,
        "description": "The risk or severity of adverse effects can be increased when Furosemide is combined with Amiodarone."
      },
      {
        "drug1": "digoxin",
        "drug2": "amiodarone",
        "drug1_id": "DB00390",
        "drug2_id": "DB01118",
        "severity": "Major interaction",
        "severity_score": 7.0,
        "description": "The serum concentration of Digoxin can be increased when it is combined with Amiodarone."
      }
    ],
    "template_explanation": "\ud83d\udfe0 HIGH RISK IDENTIFIED (Score: 0.77)\n\nThis medication combination has SIGNIFICANT interaction risks:\n\u2022 Major drug interactions detected that require attention\n\u2022 Monitoring and possible medication adjustments recommended\n\nKey interactions:\n- digoxin + furosemide: Contraindicated interaction\n  Description: The risk or severity of adverse effects can be increased when Furosemide is combined with Digoxin....\n- amiodarone + furosemide: Contraindicated interaction\n  Description: The risk or severity of adverse effects can be increased when Furosemide is combined with Amiodarone....\n- digoxin + amiodarone: Major interaction\n  Description: The serum concentration of Digoxin can be increased when it is combined with Amiodarone....\n\nRECOMMENDATION: Schedule appointment with healthcare provider to review medications.",
    "llm_explanation": "[LLM not available]"
  },
  {
    "case_id": "case_007",
    "drugs": [
      "fluoxetine",
      "tramadol",
      "alprazolam"
    ],
    "kg_risk_level": "MODERATE",
    "kg_risk_score": 0.40770958300733146,
    "kg_interactions": [],
    "template_explanation": "\ud83d\udfe1 MODERATE RISK (Score: 0.41)\n\nThis medication combination has some interaction concerns:\n\u2022 Interactions detected but generally manageable\n\u2022 Monitoring recommended\n\nKey points:\nNo significant interactions found.\n\nRECOMMENDATION: Discuss at next regular appointment with your provider.",
    "llm_explanation": "[LLM not available]"
  },
  {
    "case_id": "case_008",
    "drugs": [
      "simvastatin",
      "amiodarone",
      "diltiazem"
    ],
    "kg_risk_level": "HIGH",
    "kg_risk_score": 0.7757274913790606,
    "kg_interactions": [
      {
        "drug1": "amiodarone",
        "drug2": "diltiazem",
        "drug1_id": "DB01118",
        "drug2_id": "DB00343",
        "severity": "Contraindicated interaction",
        "severity_score": 10.0,
        "description": "The risk or severity of adverse effects can be increased when Amiodarone is combined with Diltiazem."
      },
      {
        "drug1": "simvastatin",
        "drug2": "amiodarone",
        "drug1_id": "DB00641",
        "drug2_id": "DB01118",
        "severity": "Major interaction",
        "severity_score": 7.0,
        "description": "The serum concentration of Simvastatin can be increased when it is combined with Amiodarone."
      },
      {
        "drug1": "simvastatin",
        "drug2": "diltiazem",
        "drug1_id": "DB00641",
        "drug2_id": "DB00343",
        "severity": "Major interaction",
        "severity_score": 7.0,
        "description": "The serum concentration of Simvastatin can be increased when it is combined with Diltiazem."
      }
    ],
    "template_explanation": "\ud83d\udfe0 HIGH RISK IDENTIFIED (Score: 0.78)\n\nThis medication combination has SIGNIFICANT interaction risks:\n\u2022 Major drug interactions detected that require attention\n\u2022 Monitoring and possible medication adjustments recommended\n\nKey interactions:\n- amiodarone + diltiazem: Contraindicated interaction\n  Description: The risk or severity of adverse effects can be increased when Amiodarone is combined with Diltiazem....\n- simvastatin + amiodarone: Major interaction\n  Description: The serum concentration of Simvastatin can be increased when it is combined with Amiodarone....\n- simvastatin + diltiazem: Major interaction\n  Description: The serum concentration of Simvastatin can be increased when it is combined with Diltiazem....\n\nRECOMMENDATION: Schedule appointment with healthcare provider to review medications.",
    "llm_explanation": "[LLM not available]"
  },
  {
    "case_id": "case_009",
    "drugs": [
      "atorvastatin",
      "amlodipine",
      "lisinopril"
    ],
    "kg_risk_level": "LOW",
    "kg_risk_score": 0.34074734127329104,
    "kg_interactions": [],
    "template_explanation": "\ud83d\udfe2 LOW RISK (Score: 0.34)\n\nThis medication combination appears generally safe:\n\u2022 Only minor interactions detected\n\u2022 Continue regular monitoring\n\nNote: Always inform your healthcare providers of all medications you take.",
    "llm_explanation": "[LLM not available]"
  },
  {
    "case_id": "case_010",
    "drugs": [
      "metformin",
      "glipizide",
      "lisinopril"
    ],
    "kg_risk_level": "MODERATE",
    "kg_risk_score": 0.49808281897476026,
    "kg_interactions": [
      {
        "drug1": "metformin",
        "drug2": "lisinopril",
        "drug1_id": "DB00331",
        "drug2_id": "DB00722",
        "severity": "Contraindicated interaction",
        "severity_score": 10.0,
        "description": "The risk or severity of lactic acidosis can be increased when Lisinopril is combined with Metformin."
      },
      {
        "drug1": "glipizide",
        "drug2": "lisinopril",
        "drug1_id": "DB01067",
        "drug2_id": "DB00722",
        "severity": "Major interaction",
        "severity_score": 7.0,
        "description": "Lisinopril may decrease the excretion rate of Glipizide which could result in a higher serum level."
      }
    ],
    "template_explanation": "\ud83d\udfe1 MODERATE RISK (Score: 0.50)\n\nThis medication combination has some interaction concerns:\n\u2022 Interactions detected but generally manageable\n\u2022 Monitoring recommended\n\nKey points:\n- metformin + lisinopril: Contraindicated interaction\n  Description: The risk or severity of lactic acidosis can be increased when Lisinopril is combined with Metformin....\n- glipizide + lisinopril: Major interaction\n  Description: Lisinopril may decrease the excretion rate of Glipizide which could result in a higher serum level....\n\nRECOMMENDATION: Discuss at next regular appointment with your provider.",
    "llm_explanation": "[LLM not available]"
  },
  {
    "case_id": "case_011",
    "drugs": [
      "omeprazole",
      "clopidogrel",
      "metoprolol"
    ],
    "kg_risk_level": "MODERATE",
    "kg_risk_score": 0.5682778405633313,
    "kg_interactions": [
      {
        "drug1": "omeprazole",
        "drug2": "clopidogrel",
        "drug1_id": "DB00338",
        "drug2_id": "DB00758",
        "severity": "Contraindicated interaction",
        "severity_score": 10.0,
        "description": "The serum concentration of the active metabolites of Clopidogrel can be reduced when Clopidogrel is used in combination with Omeprazole resulting in a loss in efficacy."
      }
    ],
    "template_explanation": "\ud83d\udfe1 MODERATE RISK (Score: 0.57)\n\nThis medication combination has some interaction concerns:\n\u2022 Interactions detected but generally manageable\n\u2022 Monitoring recommended\n\nKey points:\n- omeprazole + clopidogrel: Contraindicated interaction\n  Description: The serum concentration of the active metabolites of Clopidogrel can be reduced when Clopidogrel is used in combination with Omeprazole resulting in a...\n\nRECOMMENDATION: Discuss at next regular appointment with your provider.",
    "llm_explanation": "[LLM not available]"
  },
  {
    "case_id": "case_012",
    "drugs": [
      "sertraline",
      "trazodone",
      "alprazolam"
    ],
    "kg_risk_level": "MODERATE",
    "kg_risk_score": 0.4089991016836188,
    "kg_interactions": [],
    "template_explanation": "\ud83d\udfe1 MODERATE RISK (Score: 0.41)\n\nThis medication combination has some interaction concerns:\n\u2022 Interactions detected but generally manageable\n\u2022 Monitoring recommended\n\nKey points:\nNo significant interactions found.\n\nRECOMMENDATION: Discuss at next regular appointment with your provider.",
    "llm_explanation": "[LLM not available]"
  },
  {
    "case_id": "case_013",
    "drugs": [
      "gabapentin",
      "pregabalin",
      "duloxetine"
    ],
    "kg_risk_level": "LOW",
    "kg_risk_score": 0.30743139470862674,
    "kg_interactions": [],
    "template_explanation": "\ud83d\udfe2 LOW RISK (Score: 0.31)\n\nThis medication combination appears generally safe:\n\u2022 Only minor interactions detected\n\u2022 Continue regular monitoring\n\nNote: Always inform your healthcare providers of all medications you take.",
    "llm_explanation": "[LLM not available]"
  },
  {
    "case_id": "case_014",
    "drugs": [
      "acetaminophen",
      "ibuprofen",
      "omeprazole"
    ],
    "kg_risk_level": "MODERATE",
    "kg_risk_score": 0.4240198209162827,
    "kg_interactions": [],
    "template_explanation": "\ud83d\udfe1 MODERATE RISK (Score: 0.42)\n\nThis medication combination has some interaction concerns:\n\u2022 Interactions detected but generally manageable\n\u2022 Monitoring recommended\n\nKey points:\nNo significant interactions found.\n\nRECOMMENDATION: Discuss at next regular appointment with your provider.",
    "llm_explanation": "[LLM not available]"
  },
  {
    "case_id": "case_015",
    "drugs": [
      "lisinopril",
      "amlodipine",
      "hydrochlorothiazide"
    ],
    "kg_risk_level": "LOW",
    "kg_risk_score": 0.35708221043785676,
    "kg_interactions": [],
    "template_explanation": "\ud83d\udfe2 LOW RISK (Score: 0.36)\n\nThis medication combination appears generally safe:\n\u2022 Only minor interactions detected\n\u2022 Continue regular monitoring\n\nNote: Always inform your healthcare providers of all medications you take.",
    "llm_explanation": "[LLM not available]"
  },
  {
    "case_id": "case_016",
    "drugs": [
      "metformin",
      "sitagliptin",
      "atorvastatin"
    ],
    "kg_risk_level": "MODERATE",
    "kg_risk_score": 0.49853849720362803,
    "kg_interactions": [
      {
        "drug1": "metformin",
        "drug2": "atorvastatin",
        "drug1_id": "DB00331",
        "drug2_id": "DB01076",
        "severity": "Contraindicated interaction",
        "severity_score": 10.0,
        "description": "Metformin may increase the hypolipidaemic activities of Atorvastatin."
      },
      {
        "drug1": "sitagliptin",
        "drug2": "atorvastatin",
        "drug1_id": "DB01261",
        "drug2_id": "DB01076",
        "severity": "Major interaction",
        "severity_score": 7.0,
        "description": "The metabolism of Sitagliptin can be decreased when combined with Atorvastatin."
      }
    ],
    "template_explanation": "\ud83d\udfe1 MODERATE RISK (Score: 0.50)\n\nThis medication combination has some interaction concerns:\n\u2022 Interactions detected but generally manageable\n\u2022 Monitoring recommended\n\nKey points:\n- metformin + atorvastatin: Contraindicated interaction\n  Description: Metformin may increase the hypolipidaemic activities of Atorvastatin....\n- sitagliptin + atorvastatin: Major interaction\n  Description: The metabolism of Sitagliptin can be decreased when combined with Atorvastatin....\n\nRECOMMENDATION: Discuss at next regular appointment with your provider.",
    "llm_explanation": "[LLM not available]"
  },
  {
    "case_id": "case_017",
    "drugs": [
      "levothyroxine",
      "calcium",
      "vitamin d"
    ],
    "kg_risk_level": "MINIMAL",
    "kg_risk_score": 0.12079602422556435,
    "kg_interactions": [],
    "template_explanation": "Risk Level: MINIMAL (Score: 0.12)",
    "llm_explanation": "[LLM not available]"
  }
]